Literature DB >> 8589037

Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia.

M Le Coniat1, S P Romana, R Berger.   

Abstract

Monosomy 21 and metacentric markers corresponding in size to chromosomes 8 to 12 were found as the only clonal chromosomal changes in a child with acute lymphoblastic leukemia (ALL). chromosome painting with a whole chromosome 21-specific probe showed that the marker originated from chromosome 21. Fluorescence in situ hybridization with yeast artificial chromosome (YAC) probes to chromosome 21 showed genomic amplification with two, four, or more copies of the probed DNA sequences present on the marker. The most amplified regions of chromosome 21 were centromeric and telomeric to the Down's syndrome region. This observation supports the notion that amplification of only parts of chromosome 21 may be important in the leukemogenic process in spite of the high incidence of complete trisomy 21 in ALL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589037     DOI: 10.1002/gcc.2870140308

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  2 in total

1.  No chromosome arm unturned: in memory of Roland Berger 1934-2012.

Authors:  C J Harrison; J D Rowley; H Van den Berghe; A Bernheim; M Martineau; M Gautier; M Le Coniat-Busson; S Romana; N Dastugue; A Hagemeijer; P Jonveaux; F Nguyen-Khac; O A Bernard
Journal:  Leukemia       Date:  2014-02       Impact factor: 11.528

2.  An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Authors:  C J Harrison; A V Moorman; C Schwab; A J Carroll; E A Raetz; M Devidas; S Strehl; K Nebral; J Harbott; A Teigler-Schlegel; M Zimmerman; N Dastuge; A Baruchel; J Soulier; M-F Auclerc; A Attarbaschi; G Mann; B Stark; G Cazzaniga; L Chilton; P Vandenberghe; E Forestier; I Haltrich; S C Raimondi; M Parihar; J-P Bourquin; J Tchinda; C Haferlach; A Vora; S P Hunger; N A Heerema; O A Haas
Journal:  Leukemia       Date:  2013-10-29       Impact factor: 11.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.